PACIRA BIOSCIENCES, INC. (PCRX) FY2026 YTD Q2 Statement of Cash Flows
2026-01-01 to 2026-06-30
Statement of Cash Flows
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
PACIRA BIOSCIENCES, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026
Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 31, 2025
- 158,545,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 83,140,000 US dollars. Net cash provided.
- Net income (loss)
- 7,569,000 US dollars
- Deferred taxes
- 5,644,000 US dollars
- Accounts receivable, net
- negative 12,074,000 US dollars
- Other liabilities
- 4,359,000 US dollars
- Depreciation of fixed assets and amortization of intangible assets
- 42,626,000 US dollars
- Changes in contingent consideration
- negative 614,000 US dollars
- Prepaid expenses and other assets
- 378,000 US dollars
- Inventories, net
- 8,451,000 US dollars
- Accrued expenses
- 1,563,000 US dollars
- Amortization of debt issuance costs and debt discount
- 1,154,000 US dollars
- Other net gains
- 0 US dollars
- Stock-based compensation
- 28,497,000 US dollars
- Accounts payable
- 2,248,000 US dollars
- Net accretion of discount on available-for-sale investments
- negative 927,000 US dollars
- Investment impairment
- 0 US dollars
- Release of valuation allowance on deferred tax assets
- negative 6,397,000 US dollars
- Amortization of cloud computing arrangements
- 663,000 US dollars
- Investing activities
- 31,200,000 US dollars. Net cash provided.
- Acquisition of GQ Bio Therapeutics GmbH (net of cash acquired)
- negative 335,000 US dollars
- Sales of available-for-sale investments
- 39,500,000 US dollars
- Purchases of fixed assets
- negative 4,060,000 US dollars
- Purchases of available-for-sale investments
- negative 3,905,000 US dollars
- Purchase of convertible notes receivable investment
- 0 US dollars
- Financing activities
- negative 67,048,000 US dollars. Net cash used.
- Proceeds from exercises of stock options
- 459,000 US dollars
- Payment of employee withholding taxes on restricted stock unit vests
- negative 7,848,000 US dollars
- Purchase of treasury stock, inclusive of broker fees
- negative 50,045,000 US dollars
- Repayment of Term loan A facility
- 0 US dollars
- Repayment of Revolving Credit Facility
- negative 10,000,000 US dollars
- Proceeds from shares issued under employee stock purchase plan
- 1,722,000 US dollars
- Excise taxes paid on treasury stock repurchases
- negative 1,336,000 US dollars
- Operating adjustment reconciliation
- 95,583,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 69,229,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 39,500,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 38,000 US dollars
- Ending cash on Jun 30, 2026
- 205,875,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 272,923,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 47,330,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 10.98×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 83,140,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 4,060,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 79,080,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $75.57M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 83,140,000 US dollars minus 4,060,000 US dollars equals 79,080,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!